Answer
No. It is licensed as an add-on to levodopa combined with a DOPA decarboxylase inhibitor and has no useful Parkinson’s effect by itself.
Sources for this answer
- Ongentys 50 mg hard capsulesemc · SmPC Current selected SmPC · Version 7
- NHSNHS · NHS medicine guidance